The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.
The grant aims to advance precision medicine for pregnant and lactating persons, including children, through the development of novel tools, models, and technologies with direct clinical or health impact. It seeks to enhance understanding of drug action mechanisms, considering developmental physiology and changes during pregnancy and lactation. The goal is to discover, develop, or better utilize therapeutics for safer and more effective medication use in these populations, ultimately improving precision therapeutics for pregnant and lactating persons, fetuses, neonates, and children, including those with disabilities.